Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Santa Elizabeth Ceballos‐Liceaga"'
Autor:
Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Iván Valdés-Ferrer, Carlos A. Fermín-Martínez, Luisa Fernández-Chirino, Arsenio Vargas-Vázquez, Daniel Ramírez-García, Javier Mancilla-Galindo, Ashuin Kammar-García, José Alberto Ávila-Funes, Clemente Humberto Zúñiga-Gil, Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, José Antonio Montes-González, Christian Arturo Zaragoza-Jiménez, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Gustavo Reyes-Terán, Hugo López-Gatell, Luis Miguel Gutiérrez-Robledo
Publikováno v:
International Journal of Infectious Diseases, Vol 129, Iss , Pp 188-196 (2023)
ABSTRACT: Objectives: Vaccination has been effective in ameliorating the impact of COVID-19. Here, we report vaccine effectiveness (VE) of the nationally available COVID-19 vaccines in Mexico. Methods: Retrospective analysis of a COVID-19 surveillanc
Externí odkaz:
https://doaj.org/article/0e84a4f545a54d1ca264b7f043e4055d
Autor:
Mario García-Alanis, Marisa Morales-Cárdenas, Liz Nicole Toapanta-Yanchapaxi, Erwin Chiquete, Isaac Núñez, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, Carla Toledo-Salinas, David Alejandro Mendoza-Hernández, Selma Cecilia Scheffler-Mendoza, José Antonio Ortega-Martell, Daniel Armando Carrillo-García, Noé Hernández-Valdivia, Alonso Gutiérrez-Romero, Javier Andrés Galnares-Olalde, Fernando Daniel Flores-Silva, José Luis Díaz-Ortega, Gustavo Reyes-Terán, Hugo López-Gatell, Ricardo Cortes-Alcalá, José Rogelio Pérez-Padilla, Antonio Arauz, Miguel García-Grimshaw, Sergio Iván Valdés-Ferrer
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1297 (2022)
Background: Despite the high number of vaccines administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, the information on the psychological/psychiatric adverse events following immunization (AEFI) with these newl
Externí odkaz:
https://doaj.org/article/3e0a319b5eb548e48b0244b63a67043a
Autor:
Cesar A. Mendez-Lizarraga, Enrique Chacon-Cruz, Ricardo Carrillo-Meza, Néstor Saúl Hernández-Milán, Leslie C. Inustroza-Sánchez, Diego F. Ovalle-Marroquín, Jesús René Machado-Contreras, Omar Ceballos Zuñiga, Verónica Bejarano-Ramírez, Cipriano Aguilar-Aguayo, Adrián Medina-Amarillas, Santa Elizabeth Ceballos-Liceaga, Oscar E. Zazueta
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1196 (2022)
After emergency authorization, different COVID-19 vaccines were administered across Mexico in 2021, including mRNA, viral vector, and inactivated platform vaccines. In the state of Baja-California, 3,516,394 doses were administered, and 2285 adverse
Externí odkaz:
https://doaj.org/article/52d00dd984eb45bbbf82a1da00d5963b
Autor:
Diego López-Mena, Miguel García-Grimshaw, Sergio Saldivar-Dávila, Laura Elena Hernandez-Vanegas, María del Mar Saniger-Alba, Alonso Gutiérrez-Romero, Roger Carrillo-Mezo, Hector Eduardo Valdez-Ruvalcaba, Vanessa Cano-Nigenda, Fernando Daniel Flores-Silva, Carlos Cantú-Brito, Ana María Santibañez-Copado, Jose-Luis Diaz-Ortega, Santa Elizabeth Ceballos-Liceaga, Luis Manuel Murillo-Bonilla, Ana Isabel Sepulveda-Núñez, Verónica García-Talavera, Eduardo Gonzalez-Guerra, Ricardo Cortes-Alcala, Hugo Lopez-Gatell, Guillermo Carbajal-Sandoval, Gustavo Reyes-Terán, Sergio Iván Valdés-Ferrer, Antonio Arauz
Publikováno v:
Neurology
Background and ObjectivesInformation on stroke among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines remains scarce. We report stroke incidence as an adverse event following immunization (AEFI) among recipients of 79,399,446 dos
Autor:
Isaac Núñez, Miguel García‐Grimshaw, Carlos Yoel Castillo Valencia, Daniel Eduardo Aguilera Callejas, Mónica Libertad Moya Alfaro, María del Mar Saniger‐Alba, Alonso Gutiérrez‐Romero, Roger Carrillo‐Mezo, Santa Elizabeth Ceballos‐Liceaga, Raúl C. Baptista‐Rosas, Hugo López‐Gatell, Gustavo Reyes‐Terán, Jose Luis Díaz‐Ortega, Antonio Arauz, Sergio Iván Valdés‐Ferrer, Laura E. Hernández‐Vanegas
Publikováno v:
Epilepsia. 63
The COVID-19 pandemic led to the development and emergency approval of an array of effective vaccines against SARS-CoV-2. Given the relatively small number of patients included in vaccine trials, postapproval epidemiological surveillance is crucial t
Autor:
Miguel García‐Grimshaw, Javier Andrés Galnares‐Olalde, Omar Yaxmehen Bello‐Chavolla, Anaclara Michel‐Chávez, Arturo Cadena‐Fernández, María Eugenia Briseño‐Godínez, Neftali Eduardo Antonio‐Villa, Isaac Núñez, Alonso Gutiérrez‐Romero, Laura Hernández‐Vanegas, María del Mar Saniger‐Alba, Roger Carrillo‐Mezo, Santa Elizabeth Ceballos‐Liceaga, Guillermo Carbajal‐Sandoval, Fernando Daniel Flores‐Silva, José Luis Díaz‐Ortega, Ricardo Cortes‐Alcalá, José Rogelio Pérez‐Padilla, Hugo López‐Gatell, Erwin Chiquete, Gustavo Reyes‐Terán, Antonio Arauz, Sergio Iván Valdés‐Ferrer
Publikováno v:
European journal of neurologyREFERENCES. 29(11)
Information on Guillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 remains scarce. We aimed to report GBS incidence as an AEFI among adult (≥18 years) recipients of 81,842,426 doses of seven anti-SARS
Autor:
Miguel García-Grimshaw, Javier Andrés Galnares-Olalde, Omar Yaxmehen Bello-Chavolla, Anaclara Michel-Chávez, Arturo Cadena-Fernández, María Eugenia Briseño-Godínez, Neftali Eduardo Antonio-Villa, Isaac Nuñez, Alonso Gutiérrez-Romero, Laura Hernández-Vanegas, María del Mar Saniger-Alba, Roger Carrillo-Mezo, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, Fernando Daniel Flores-Silva, José Luis Díaz-Ortega, Hugo López-Gatell, Ricardo Cortes-Alcalá, José Rogelio Pérez-Padilla, Erwin Chiquete, Gustavo Reyes-Terán, Antonio Arauz, Sergio Iván Valdés-Ferrer
SummaryBackgroundGuillain-Barré syndrome (GBS) as an adverse event following immunization (AEFI) against SARS-CoV-2 has been linked to a few (ChAdOx1 nCov-19 and Ad26.COV2-S), but not all vaccines, including mRNA-based ones. Epidemiological informat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81f20890cca6df6bd88be66c1c3ae1f9
https://doi.org/10.1101/2022.04.11.22273754
https://doi.org/10.1101/2022.04.11.22273754
Autor:
Omar Yaxmehen Bello-Chavolla, Neftali Eduardo Antonio-Villa, Sergio Iván Valdés-Ferrer, Carlos A. Fermín-Martínez, Luisa Fernández-Chirino, Daniel Ramírez-García, Javier Mancilla-Galindo, Ashuin Kammar-García, José Alberto Ávila-Funes, Clemente Humberto Zúñiga-Gil, Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Guillermo Carbajal-Sandoval, José Antonio Montes-González, Christian Arturo Zaragoza-Jiménez, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Gustavo Reyes-Terán, Hugo López-Gatell, Luis Miguel Gutiérrez-Robledo
BACKGROUNDVaccination has been effective in ameliorating the impact of COVID-19. However, estimation of vaccine effectiveness (VE) is still unavailable for some widely used vaccines and underrepresented groups. Here, we report on the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9308b876754e576b222a3979778ae063
https://doi.org/10.1101/2022.04.04.22273330
https://doi.org/10.1101/2022.04.04.22273330
Autor:
Isaac Núñez, Miguel García-Grimshaw, Santa Elizabeth Ceballos-Liceaga, Carla Toledo-Salinas, Guillermo Carbajal Sandoval, Luisa Sosa-Laso, Gabriel García-Rodríguez, Ricardo Cortés-Alcalá, Alethse de la Torre, Sergio Fragoso-Saavedra, Alejandro Quintero-Villegas, Hugo López-Gatell, Gustavo Reyes-Terán, Sergio Ivan Valdés-Ferrer
Publikováno v:
SSRN Electronic Journal.
Autor:
Anaclara Michel-Chávez, Noé Hernández-Valdivia, Daniel Amado Carrillo-García, Santa Elizabeth Ceballos-Liceaga, Sergio I. Valdés-Ferrer, Carlos Cantú-Brito, Laura E. Hernández-Vanegas, Mario García-Alanis, Erwin Chiquete, Gustavo Reyes-Terán, Miguel García-Grimshaw, Arturo Cadena-Fernández, Guillermo Carbajal-Sandoval, Fernando Flores-Silva, Alonso Gutierrez-Romero, Hugo López-Gatell, María del Mar Saniger-Alba, Javier A. Galnares-Olalde, Antonio Arauz, José Luis Díaz-Ortega
Publikováno v:
Vaccine
mRNA-based COVID-19 vaccines are effective; however, persistent vaccine hesitancy is partly due to a misperception of their potential adverse events. Non-specific sensory symptoms (NSSS) following immunization are thought to be mediated by stress-rel